封面
市场调查报告书
商品编码
1788504

生物技术市场-全球产业分析、规模、份额、成长、趋势及预测(2025-2035)

Biotechnology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

出版日期: | 出版商: Transparency Market Research | 英文 208 Pages | 商品交期: 2-10个工作天内

价格

生物技术市场-报告范围

TMR 的全球生物技术市场报告研究了过去和当前的成长趋势和机会,以获得 2025 年至 2035 年预测期内市场指标的宝贵见解。该报告提供了 2025 年至 2035 年期间全球生技市场的收入,以 2025 年为基准年,2035 年为预测年。该报告也提供了 2025 年至 2035 年全球生物技术市场的年复合成长率(CAGR %)。

本报告经过广泛调查后编写。主要研究工作包括分析师对关键意见领袖、产业领导者和舆论领袖进行访谈。次要研究则参考了主要厂商的产品资料、年度报告、新闻稿和相关文件,以了解两轮车导航显示器市场。

市场概况
2024 年的市场价值 1.8兆美元
2035年的市场价值 5.4兆美元
复合年增长率 10.3%

本报告深入探讨了全球两轮车导航显示器市场的竞争格局。报告确定了全球生物技术市场的主要参与者,并根据其各项属性进行了分析。本报告对全球生物技术市场参与者的属性进行了分析,涵盖公司概况、财务状况、近期发展和 SWOT 分析。

全球生物技术市场报告解答的关键问题:

  • 预测期内,所有地区的血液分离术所产生的销售额/收入为何?
  • 全球两轮车导航显示器市场有哪些机会?
  • 市场的主要驱动因素、限制因素、机会和威胁是什么?
  • 在预测期内,哪个区域市场将以最快的复合年增长率扩张?
  • 预计哪个领域将在 2035 年创造全球最高收入?
  • 预测期间哪一个部分的复合年增长率预计最高?
  • 在全球市场上营运的不同公司的市场地位如何?

生物技术市场-研究目标与研究方法

这份关于全球生物技术市场的综合报告首先概述了研究范围和目标。报告详细阐述了本研究的目标、市场中的主要供应商和分销商,以及产品审批的监管情况。

为了方便阅读,本报告采用章节式布局,每个章节又细分为多个小节。报告包含详尽的图表,并适当穿插。各关键细分市场的实际值和预测值以图形方式呈现,视觉上引人入胜。此外,报告也便于读者比较过去和预测期末各关键细分市场的市占率。

本报告从产品、最终用户和地区三个角度分析了全球生物技术市场。该报告对每个标准下的关键细分市场进行了深入研究,并提供了截至2035年底每个细分市场的市场份额。这些宝贵的洞察有助于市场利害关係人在全球两轮车导航显示器市场投资时做出明智的商业决策。

目录

第一章:前言

第二章:假设与研究方法

第三章:执行摘要:全球市场

第四章:市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2020年至2035年全球生技市场分析与预测

第五章:关键见解

  • 主要地区/国家的医疗保健支出
  • 技术进步
  • 主要地区/国家的监管情况
  • 波特五力分析
  • PESTEL分析
  • 价值链分析
  • 最终用户的关键购买指标
  • 新市场进入者的市场进入策略
  • 重要产业事件(合作伙伴关係、协作、产品批准、合併和收购)
  • 与领先竞争对手的关键技术基准化分析

第六章:全球市场分析与预测:依技术

  • 介绍和定义
  • 主要发现/进展
  • 2020 年至 2035 年各技术市场价值预测
    • 聚合酶炼式反应(PCR)技术
    • 组织工程与再生
    • 奈米生物技术
    • 色谱法
    • DNA定序
    • 基于细胞的检测
    • 发酵
    • 生物资讯学
    • 其他的
  • 按技术分類的市场吸引力

第七章:全球市场分析与预测:按应用

  • 介绍和定义
  • 主要发现/进展
  • 2020 年至 2035 年各应用市场价值预测
    • 卫生保健
    • 农业
    • 食品和饮料
    • 工业生物技术
    • 环境生物技术
    • 其他的
  • 按应用分類的市场吸引力

第八章:全球市场分析与预测:按地区

  • 主要发现
  • 各地区市场价值预测
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 各地区市场吸引力

第九章:北美市场分析与预测

  • 我们
  • 加拿大

第十章:欧洲市场分析与预测

  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 瑞士
  • 荷兰
  • 欧洲其他地区

第 11 章:亚太市场分析与预测

  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲和纽西兰
  • 亚太其他地区

第十二章:拉丁美洲市场分析与预测

  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区

第十三章:中东和非洲市场分析与预测

  • 海湾合作委员会国家
  • 南非
  • 中东和非洲其他地区

第 14 章:竞争格局

  • 市场参与者 - 竞争矩阵(依公司层级和规模)
  • 各公司市占率分析(2024 年)
  • 公司简介
    • Abbott
    • AstraZeneca
    • Pfizer Inc.
    • F. Hoffmann-La Roche AG
    • Novartis AG
    • Merck & Co., Inc.
    • Eli Lilly and Company
    • Novo Nordisk A/S
    • Merck KGaA
    • Johnson & Johnson Services, Inc.
    • Amgen Inc.
    • GSK plc
    • Sanofi
    • Thermo Fisher Scientific Inc.
    • AbbVie Inc.
    • Bristol-Myers Squibb Company
    • Teva Pharmaceutical Industries Ltd.
    • Gilead Sciences, Inc.
    • Biogen Inc.
    • Moderna, Inc.
Product Code: TMRGL86738

Biotechnology Market- Scope of Report

TMR's report on the global Biotechnology Marketstudies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global Biotechnology Marketfor the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Biotechnology Marketfrom 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the two-wheeler navigation display market.

Market Snapshot
Market Value in 2024US$ 1.8 Tn
Market Value in 2035US$ 5.4 Tn
CAGR10.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global two-wheeler navigation display market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global two-wheeler navigation display market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global two-wheeler navigation display market.

The report delves into the competitive landscape of the global two-wheeler navigation display market. Key players operating in the global Biotechnology Markethave been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Biotechnology Marketprofiled in this report.

Key Questions Answered in Global Biotechnology MarketReport:

  • What is the sales/revenue generated by apheresis across all regions during the forecast period?
  • What are the opportunities in the global two-wheeler navigation display market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Biotechnology Market- Research Objectives and Research Approach

The comprehensive report on the global Biotechnology Marketbegins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Biotechnology Marketin terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global two-wheeler navigation display market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Biotechnology Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Biotechnology Market Analysis and Forecasts, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Tn)

5. Key Insights

  • 5.1. Healthcare Expenditure across Key Regions / Countries
  • 5.2. Technological Advancements
  • 5.3. Regulatory Scenario across Key Regions / Countries
  • 5.4. PORTER's Five Forces Analysis
  • 5.5. PESTEL Analysis
  • 5.6. Value Chain Analysis
  • 5.7. Key Purchase Metrics for End-users
  • 5.8. Go-to-Market Strategy for New Market Entrants
  • 5.9. Key Industry Events (Partnerships, Collaborations, Product approvals, Mergers & acquisitions)
  • 5.10. Benchmarking of Key Technologies Offered by the Leading Competitors

6. Global Biotechnology Market Analysis and Forecasts, By Technology

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Technology, 2020 to 2035
    • 6.3.1. Polymerase Chain Reaction (PCR) Technology
    • 6.3.2. Tissue Engineering and Regeneration
    • 6.3.3. Nanobiotechnology
    • 6.3.4. Chromatography
    • 6.3.5. DNA Sequencing
    • 6.3.6. Cell-based Assays
    • 6.3.7. Fermentation
    • 6.3.8. Bioinformatics
    • 6.3.9. Others
  • 6.4. Market Attractiveness By Technology

7. Global Biotechnology Market Analysis and Forecasts, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Application, 2020 to 2035
    • 7.3.1. Healthcare
    • 7.3.2. Agriculture
    • 7.3.3. Food & Beverages
    • 7.3.4. Industrial Biotechnology
    • 7.3.5. Environmental Biotechnology
    • 7.3.6. Others
  • 7.4. Market Attractiveness By Application

8. Global Biotechnology Market Analysis and Forecasts, By Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast By Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness By Region

9. North America Biotechnology Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast By Technology, 2020 to 2035
    • 9.2.1. Polymerase Chain Reaction (PCR) Technology
    • 9.2.2. Tissue Engineering and Regeneration
    • 9.2.3. Nanobiotechnology
    • 9.2.4. Chromatography
    • 9.2.5. DNA Sequencing
    • 9.2.6. Cell-based Assays
    • 9.2.7. Fermentation
    • 9.2.8. Bioinformatics
    • 9.2.9. Others
  • 9.3. Market Value Forecast By Application, 2020 to 2035
    • 9.3.1. Healthcare
    • 9.3.2. Agriculture
    • 9.3.3. Food & Beverages
    • 9.3.4. Industrial Biotechnology
    • 9.3.5. Environmental Biotechnology
    • 9.3.6. Others
  • 9.4. Market Value Forecast By Country, 2020 to 2035
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Technology
    • 9.5.2. By Application
    • 9.5.3. By Country

10. Europe Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Technology, 2020 to 2035
    • 10.2.1. Polymerase Chain Reaction (PCR) Technology
    • 10.2.2. Tissue Engineering and Regeneration
    • 10.2.3. Nanobiotechnology
    • 10.2.4. Chromatography
    • 10.2.5. DNA Sequencing
    • 10.2.6. Cell-based Assays
    • 10.2.7. Fermentation
    • 10.2.8. Bioinformatics
    • 10.2.9. Others
  • 10.3. Market Value Forecast By Application, 2020 to 2035
    • 10.3.1. Healthcare
    • 10.3.2. Agriculture
    • 10.3.3. Food & Beverages
    • 10.3.4. Industrial Biotechnology
    • 10.3.5. Environmental Biotechnology
    • 10.3.6. Others
  • 10.4. Market Value Forecast By Country / Sub-region, 2020 to 2035
    • 10.4.1. Germany
    • 10.4.2. UK
    • 10.4.3. France
    • 10.4.4. Italy
    • 10.4.5. Spain
    • 10.4.6. Switzerland
    • 10.4.7. The Netherlands
    • 10.4.8. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Technology
    • 10.5.2. By Application
    • 10.5.3. By Country / Sub-region

11. Asia Pacific Biotechnology Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Technology, 2020 to 2035
    • 11.2.1. Polymerase Chain Reaction (PCR) Technology
    • 11.2.2. Tissue Engineering and Regeneration
    • 11.2.3. Nanobiotechnology
    • 11.2.4. Chromatography
    • 11.2.5. DNA Sequencing
    • 11.2.6. Cell-based Assays
    • 11.2.7. Fermentation
    • 11.2.8. Bioinformatics
    • 11.2.9. Others
  • 11.3. Market Value Forecast By Application, 2020 to 2035
    • 11.3.1. Healthcare
    • 11.3.2. Agriculture
    • 11.3.3. Food & Beverages
    • 11.3.4. Industrial Biotechnology
    • 11.3.5. Environmental Biotechnology
    • 11.3.6. Others
  • 11.4. Market Value Forecast By Country / Sub-region, 2020 to 2035
    • 11.4.1. China
    • 11.4.2. India
    • 11.4.3. Japan
    • 11.4.4. South Korea
    • 11.4.5. Australia & New Zealand
    • 11.4.6. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Technology
    • 11.5.2. By Application
    • 11.5.3. By Country / Sub-region

12. Latin America Biotechnology Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Technology, 2020 to 2035
    • 12.2.1. Polymerase Chain Reaction (PCR) Technology
    • 12.2.2. Tissue Engineering and Regeneration
    • 12.2.3. Nanobiotechnology
    • 12.2.4. Chromatography
    • 12.2.5. DNA Sequencing
    • 12.2.6. Cell-based Assays
    • 12.2.7. Fermentation
    • 12.2.8. Bioinformatics
    • 12.2.9. Others
  • 12.3. Market Value Forecast By Application, 2020 to 2035
    • 12.3.1. Healthcare
    • 12.3.2. Agriculture
    • 12.3.3. Food & Beverages
    • 12.3.4. Industrial Biotechnology
    • 12.3.5. Environmental Biotechnology
    • 12.3.6. Others
  • 12.4. Market Value Forecast By Country / Sub-region, 2020 to 2035
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Argentina
    • 12.4.4. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Technology
    • 12.5.2. By Application
    • 12.5.3. By Country / Sub-region

13. Middle East & Africa Biotechnology Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Technology, 2020 to 2035
    • 13.2.1. Polymerase Chain Reaction (PCR) Technology
    • 13.2.2. Tissue Engineering and Regeneration
    • 13.2.3. Nanobiotechnology
    • 13.2.4. Chromatography
    • 13.2.5. DNA Sequencing
    • 13.2.6. Cell-based Assays
    • 13.2.7. Fermentation
    • 13.2.8. Bioinformatics
    • 13.2.9. Others
  • 13.3. Market Value Forecast By Application, 2020 to 2035
    • 13.3.1. Healthcare
    • 13.3.2. Agriculture
    • 13.3.3. Food & Beverages
    • 13.3.4. Industrial Biotechnology
    • 13.3.5. Environmental Biotechnology
    • 13.3.6. Others
  • 13.4. Market Value Forecast By Country / Sub-region, 2020 to 2035
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Technology
    • 13.5.2. By Application
    • 13.5.3. By Country / Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 14.2. Market Share Analysis By Company (2024)
  • 14.3. Company Profiles
    • 14.3.1. Abbott
      • 14.3.1.1. Company Overview
      • 14.3.1.2. Financial Overview
      • 14.3.1.3. Product Portfolio
      • 14.3.1.4. Business Strategies
      • 14.3.1.5. Recent Developments
    • 14.3.2. AstraZeneca
      • 14.3.2.1. Company Overview
      • 14.3.2.2. Financial Overview
      • 14.3.2.3. Product Portfolio
      • 14.3.2.4. Business Strategies
      • 14.3.2.5. Recent Developments
    • 14.3.3. Pfizer Inc.
      • 14.3.3.1. Company Overview
      • 14.3.3.2. Financial Overview
      • 14.3.3.3. Product Portfolio
      • 14.3.3.4. Business Strategies
      • 14.3.3.5. Recent Developments
    • 14.3.4. F. Hoffmann-La Roche AG
      • 14.3.4.1. Company Overview
      • 14.3.4.2. Financial Overview
      • 14.3.4.3. Product Portfolio
      • 14.3.4.4. Business Strategies
      • 14.3.4.5. Recent Developments
    • 14.3.5. Novartis AG
      • 14.3.5.1. Company Overview
      • 14.3.5.2. Financial Overview
      • 14.3.5.3. Product Portfolio
      • 14.3.5.4. Business Strategies
      • 14.3.5.5. Recent Developments
    • 14.3.6. Merck & Co., Inc.
      • 14.3.6.1. Company Overview
      • 14.3.6.2. Financial Overview
      • 14.3.6.3. Product Portfolio
      • 14.3.6.4. Business Strategies
      • 14.3.6.5. Recent Developments
    • 14.3.7. Eli Lilly and Company
      • 14.3.7.1. Company Overview
      • 14.3.7.2. Financial Overview
      • 14.3.7.3. Product Portfolio
      • 14.3.7.4. Business Strategies
      • 14.3.7.5. Recent Developments
    • 14.3.8. Novo Nordisk A/S
      • 14.3.8.1. Company Overview
      • 14.3.8.2. Financial Overview
      • 14.3.8.3. Product Portfolio
      • 14.3.8.4. Business Strategies
      • 14.3.8.5. Recent Developments
    • 14.3.9. Merck KGaA
      • 14.3.9.1. Company Overview
      • 14.3.9.2. Financial Overview
      • 14.3.9.3. Product Portfolio
      • 14.3.9.4. Business Strategies
      • 14.3.9.5. Recent Developments
    • 14.3.10. Johnson & Johnson Services, Inc.
      • 14.3.10.1. Company Overview
      • 14.3.10.2. Financial Overview
      • 14.3.10.3. Product Portfolio
      • 14.3.10.4. Business Strategies
      • 14.3.10.5. Recent Developments
    • 14.3.11. Amgen Inc.
      • 14.3.11.1. Company Overview
      • 14.3.11.2. Financial Overview
      • 14.3.11.3. Product Portfolio
      • 14.3.11.4. Business Strategies
      • 14.3.11.5. Recent Developments
    • 14.3.12. GSK plc
      • 14.3.12.1. Company Overview
      • 14.3.12.2. Financial Overview
      • 14.3.12.3. Product Portfolio
      • 14.3.12.4. Business Strategies
      • 14.3.12.5. Recent Developments
    • 14.3.13. Sanofi
      • 14.3.13.1. Company Overview
      • 14.3.13.2. Financial Overview
      • 14.3.13.3. Product Portfolio
      • 14.3.13.4. Business Strategies
      • 14.3.13.5. Recent Developments
    • 14.3.14. Thermo Fisher Scientific Inc.
      • 14.3.14.1. Company Overview
      • 14.3.14.2. Financial Overview
      • 14.3.14.3. Product Portfolio
      • 14.3.14.4. Business Strategies
      • 14.3.14.5. Recent Developments
    • 14.3.15. AbbVie Inc.
      • 14.3.15.1. Company Overview
      • 14.3.15.2. Financial Overview
      • 14.3.15.3. Product Portfolio
      • 14.3.15.4. Business Strategies
      • 14.3.15.5. Recent Developments
    • 14.3.16. Bristol-Myers Squibb Company
      • 14.3.16.1. Company Overview
      • 14.3.16.2. Financial Overview
      • 14.3.16.3. Product Portfolio
      • 14.3.16.4. Business Strategies
      • 14.3.16.5. Recent Developments
    • 14.3.17. Teva Pharmaceutical Industries Ltd.
      • 14.3.17.1. Company Overview
      • 14.3.17.2. Financial Overview
      • 14.3.17.3. Product Portfolio
      • 14.3.17.4. Business Strategies
      • 14.3.17.5. Recent Developments
    • 14.3.18. Gilead Sciences, Inc.
      • 14.3.18.1. Company Overview
      • 14.3.18.2. Financial Overview
      • 14.3.18.3. Product Portfolio
      • 14.3.18.4. Business Strategies
      • 14.3.18.5. Recent Developments
    • 14.3.19. Biogen Inc.
      • 14.3.19.1. Company Overview
      • 14.3.19.2. Financial Overview
      • 14.3.19.3. Product Portfolio
      • 14.3.19.4. Business Strategies
      • 14.3.19.5. Recent Developments
    • 14.3.20. Moderna, Inc.
      • 14.3.20.1. Company Overview
      • 14.3.20.2. Financial Overview
      • 14.3.20.3. Product Portfolio
      • 14.3.20.4. Business Strategies
      • 14.3.20.5. Recent Developments

List of Tables

  • Table 01: Global Biotechnology Market Value (US$ Tn) Forecast, By Technology, 2020 to 2035
  • Table 02: Global Biotechnology Market Value (US$ Tn) Forecast, By Application, 2020 to 2035
  • Table 03: Global Biotechnology Market Value (US$ Tn) Forecast, By Region, 2020 to 2035
  • Table 04: North America - Biotechnology Market Value (US$ Tn) Forecast, by Country, 2020 to 2035
  • Table 05: North America - Biotechnology Market Value (US$ Tn) Forecast, By Technology, 2020 to 2035
  • Table 06: North America - Biotechnology Market Value (US$ Tn) Forecast, By Application, 2020 to 2035
  • Table 07: Europe - Biotechnology Market Value (US$ Tn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 08: Europe - Biotechnology Market Value (US$ Tn) Forecast, By Technology, 2020 to 2035
  • Table 09: Europe - Biotechnology Market Value (US$ Tn) Forecast, By Application, 2020 to 2035
  • Table 10: Asia Pacific - Biotechnology Market Value (US$ Tn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 11: Asia Pacific - Biotechnology Market Value (US$ Tn) Forecast, By Technology, 2020 to 2035
  • Table 12: Asia Pacific - Biotechnology Market Value (US$ Tn) Forecast, By Application, 2020 to 2035
  • Table 13: Latin America - Biotechnology Market Value (US$ Tn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 14: Asia Pacific - Biotechnology Market Value (US$ Tn) Forecast, By Technology, 2020 to 2035
  • Table 15: Latin America - Biotechnology Market Value (US$ Tn) Forecast, By Application, 2020 to 2035
  • Table 16: Middle East & Africa - Biotechnology Market Value (US$ Tn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 17: Middle East & Africa - Biotechnology Market Value (US$ Tn) Forecast, By Technology, 2020 to 2035
  • Table 18: Middle East & Africa - Biotechnology Market Value (US$ Tn) Forecast, By Application, 2020 to 2035

List of Figures

  • Figure 01: Global Biotechnology Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 02: Global Biotechnology Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 03: Global Biotechnology Market Revenue (US$ Tn), by Polymerase Chain Reaction (PCR) Technology, 2020 to 2035
  • Figure 04: Global Biotechnology Market Revenue (US$ Tn), by Tissue Engineering and Regeneration, 2020 to 2035
  • Figure 05: Global Biotechnology Market Revenue (US$ Tn), by Nanobiotechnology, 2020 to 2035
  • Figure 06: Global Biotechnology Market Revenue (US$ Tn), by Chromatography, 2020 to 2035
  • Figure 07: Global Biotechnology Market Revenue (US$ Tn), by DNA Sequencing, 2020 to 2035
  • Figure 08: Global Biotechnology Market Revenue (US$ Tn), by Cell-based Assays, 2020 to 2035
  • Figure 09: Global Biotechnology Market Revenue (US$ Tn), by Fermentation, 2020 to 2035
  • Figure 10: Global Biotechnology Market Revenue (US$ Tn), by Bioinformatics, 2020 to 2035
  • Figure 11: Global Biotechnology Market Revenue (US$ Tn), by Others, 2020 to 2035
  • Figure 12: Global Biotechnology Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 13: Global Biotechnology Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 14: Global Biotechnology Market Revenue (US$ Tn), by Healthcare, 2020 to 2035
  • Figure 15: Global Biotechnology Market Revenue (US$ Tn), by Agriculture, 2020 to 2035
  • Figure 16: Global Biotechnology Market Revenue (US$ Tn), by Food & Beverages, 2020 to 2035
  • Figure 17: Global Biotechnology Market Revenue (US$ Tn), by Industrial Biotechnology, 2020 to 2035
  • Figure 18: Global Biotechnology Market Revenue (US$ Tn), by Environmental Biotechnology, 2020 to 2035
  • Figure 19: Global Biotechnology Market Revenue (US$ Tn), by Others, 2020 to 2035
  • Figure 20: Global Biotechnology Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 21: Global Biotechnology Market Attractiveness Analysis, By Region, 2025 to 2035
  • Figure 22: North America - Biotechnology Market Value (US$ Tn) Forecast, 2020 to 2035
  • Figure 23: North America - Biotechnology Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 24: North America - Biotechnology Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 25: North America - Biotechnology Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 26: North America - Biotechnology Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 27: North America - Biotechnology Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 28: North America - Biotechnology Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 29: Europe - Biotechnology Market Value (US$ Tn) Forecast, 2020 to 2035
  • Figure 30: Europe - Biotechnology Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 31: Europe - Biotechnology Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 32: Europe - Biotechnology Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 33: Europe - Biotechnology Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 34: Europe - Biotechnology Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 35: Europe - Biotechnology Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 36: Asia Pacific - Biotechnology Market Value (US$ Tn) Forecast, 2020 to 2035
  • Figure 37: Asia Pacific - Biotechnology Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 38: Asia Pacific - Biotechnology Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 39: Asia Pacific - Biotechnology Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 40: Asia Pacific - Biotechnology Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 41: Asia Pacific - Biotechnology Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 42: Asia Pacific - Biotechnology Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 43: Latin America - Biotechnology Market Value (US$ Tn) Forecast, 2020 to 2035
  • Figure 44: Latin America - Biotechnology Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 45: Latin America - Biotechnology Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 46: Latin America - Biotechnology Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 47: Latin America - Biotechnology Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 48: Latin America - Biotechnology Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 49: Latin America - Biotechnology Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 50: Middle East & Africa - Biotechnology Market Value (US$ Tn) Forecast, 2020 to 2035
  • Figure 51: Middle East & Africa - Biotechnology Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 52: Middle East & Africa - Biotechnology Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 53: Middle East & Africa - Biotechnology Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 54: Middle East & Africa - Biotechnology Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 55: Middle East & Africa - Biotechnology Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 56: Middle East & Africa - Biotechnology Market Attractiveness Analysis, By Application, 2025 to 2035